Atlas Capital Advisors LLC Bristol Myers Squibb CO Transaction History

Atlas Capital Advisors LLC

  • $770 Billion
  • Q2 2024

A detailed history of Atlas Capital Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Atlas Capital Advisors LLC holds 4,800 shares of BMY stock, worth $256,176. This represents 0.03% of its overall portfolio holdings.

Number of Shares
4,800
Previous 3,390 41.59%
Holding current value
$256,176
Previous $184 Million 8.43%
% of portfolio
0.03%
Previous 0.03%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024
BUY
$40.25 - $52.99 $56,752 - $74,715
1,410 Added 41.59%
4,800 $199 Million
Q1 2024

Apr 15, 2024
SELL
$47.98 - $54.4 $67,651 - $76,704
-1,410 Reduced 29.38%
3,390 $184 Million
Q4 2023

Feb 15, 2024
SELL
$48.48 - $57.85 $45,474 - $54,263
-938 Reduced 16.35%
4,800 $246 Million
Q3 2023

Nov 14, 2023
SELL
$57.89 - $64.73 $28,829 - $32,235
-498 Reduced 7.99%
5,738 $333 Million
Q2 2023

Aug 15, 2023
SELL
$63.71 - $70.74 $64,028 - $71,093
-1,005 Reduced 13.88%
6,236 $399 Million
Q1 2023

May 16, 2023
SELL
$65.71 - $74.53 $38,111 - $43,227
-580 Reduced 7.42%
7,241 $502 Million
Q4 2022

Feb 15, 2023
BUY
$68.48 - $81.09 $8,491 - $10,055
124 Added 1.61%
7,821 $563 Million
Q3 2022

Nov 08, 2022
SELL
$0.13 - $76.84 $156 - $92,208
-1,200 Reduced 13.49%
7,697 $547 Million
Q2 2022

Aug 16, 2022
BUY
$72.62 - $79.98 $133,548 - $147,083
1,839 Added 26.06%
8,897 $685 Million
Q1 2022

May 11, 2022
SELL
$61.48 - $73.72 $4,180 - $5,012
-68 Reduced 0.95%
7,058 $515 Million
Q4 2021

Feb 01, 2022
SELL
$53.63 - $62.52 $200,308 - $233,512
-3,735 Reduced 34.39%
7,126 $444 Million
Q3 2021

Oct 28, 2021
SELL
$59.17 - $69.31 $56,862 - $66,606
-961 Reduced 8.13%
10,861 $642,000
Q2 2021

Jul 30, 2021
BUY
$61.91 - $67.42 $44,946 - $48,946
726 Added 6.54%
11,822 $789,000
Q1 2021

May 10, 2021
SELL
$59.34 - $66.74 $559,160 - $628,891
-9,423 Reduced 45.92%
11,096 $700,000
Q4 2020

Feb 16, 2021
SELL
$57.74 - $65.43 $525,029 - $594,954
-9,093 Reduced 30.71%
20,519 $1.27 Million
Q3 2020

Oct 23, 2020
SELL
$57.43 - $63.64 $88,499 - $98,069
-1,541 Reduced 4.95%
29,612 $1.79 Million
Q2 2020

Jul 28, 2020
BUY
$54.82 - $64.09 $124,222 - $145,227
2,266 Added 7.84%
31,153 $1.83 Million
Q1 2020

May 04, 2020
BUY
$46.4 - $67.43 $967,254 - $1.41 Million
20,846 Added 259.25%
28,887 $1.61 Million
Q4 2019

Jan 28, 2020
BUY
$49.21 - $64.19 $90,644 - $118,237
1,842 Added 29.71%
8,041 $516,000
Q3 2019

Nov 01, 2019
SELL
$42.77 - $50.71 $27,586 - $32,707
-645 Reduced 9.42%
6,199 $314,000
Q2 2019

Jul 25, 2019
BUY
$44.62 - $49.34 $305,379 - $337,682
6,844 New
6,844 $0
Q1 2019

Apr 29, 2019
SELL
$45.12 - $53.8 $60,054 - $71,607
-1,331 Closed
0 $0
Q2 2018

Jul 30, 2018
BUY
$50.53 - $62.98 $67,255 - $83,826
1,331 New
1,331 $0

Others Institutions Holding BMY

# of Institutions
2,429
Shares Held
1.5B
Call Options Held
29.7M
Put Options Held
32.2M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Atlas Capital Advisors LLC Portfolio

Follow Atlas Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email